The Effect of Gender-affirmative Measures on Breast Perception in Trans Men
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age16+
SponsorMedical University Innsbruck
About this trial
Breast dysphoria in transmasculine or genderdiverse individuals is a distinct psychological burden associated with depression, anxiety and suicidality. The aim is to systematically investigate the effect of GAHT (gender-affirming hormone therapy) and mastectomy on this form of dysphoria.
The primary objective of this study is to analyse and investigate the psychological and physical effects of breast development on trans men or genderdiverse individuals.
A secondary objective is to determine the extent to which the stress affects the well-being of trans men depending on the coping strategies used (binding vs. taping).
Eligibility criteria
Qualifiers
AFAB (Assigned Female At Birth)
before starting GAHT
before mastectomy
Disqualifiers
Ongoing GAHT
Mastectomy already performed
Lack of capacity to give consent
Insufficient knowledge of German
Trial design
Treatments tested in this trial
- quality of life questionnaire- iTransQoL, chest dysphoria measure
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov